twitter facebook youtube linkedin flickr webmail

Daniel R. Cahoy

Daniel R. Cahoy

Professor of Business Law and Affiliate Law Faculty

Curriculum Vitae 
Papers Available via SSRN

(814) 865-6205
Principal Office: 
University Park

J.D., Franklin Pierce Law Center
B.A., University of Iowa

Professor Daniel Cahoy specializes in the teaching and study of intellectual property law, as well as related issues in technology law and general business law concepts. A professor of business law in the Smeal College of Business, he has published numerous articles in academic law journals on topics such as IP and alternative energy policy, FDA regulatory policy, reforming the U.S. patent system, the use of contracts to extend limited intellectual property rights, and the use of experimental economics to improve jury studies. Professor Cahoy has received recognition for his work on the impact of government takings (eminent domain power) and compulsory licenses on private patent rights. In 2007, Professor Cahoy was awarded the Junior Faculty Award of Excellence, the Academy of Legal Studies in Business's highest award for a junior faculty member. He served on the Editorial Board of the peer-reviewed American Business Law Journal from 2005-2010, including as the Editor-in-Chief from 2009-2010, and now acts in an advisory capacity.

During the fall 2009 semester, Professor Cahoy was in residence at the University of Ottawa in Canada serving as the Fulbright Visiting Chair in International Humanitarian Law. His research focused on international legal mechanisms that seek to balance intellectual property rights with human rights and other social justice goals.

Professor Cahoy is a patent attorney, licensed to practice before the United States Patent and Trademark Office, and is admitted to the New York State Bar and several federal courts, including the United States Court of Appeals for the Federal Circuit. Prior to joining the University, Cahoy practiced in New York City at the large intellectual property-oriented law firm of Fitzpatrick, Cella, Harper & Scinto, where he specialized in complex patent litigation. He gained extensive experience in the development and protection of intellectual property rights in the chemical, pharmaceutical and biotechnology arts while working for such clients as Pfizer, Inc., Bristol-Myers Squibb Co., and Bausch & Lomb Incorporated. Cahoy is a graduate of Franklin Pierce Law Center, which houses one of the nation's top programs in intellectual property law. He is a member of the Academy of Legal Studies in Business and the American Intellectual Property Law Association.

Book Chapter

The Vulnerability of Middle Developed Countries to Changes in Foreign Direct Investment Arising from Intellectual Property Appropriation, in International Protection of Intellectual Property Rights (Jain & Bird eds., Edward Elgar 2009) (with Robert C. Bird)


Inverse Enclosure: Abdicating the Green Technology Landscape, 49 Am. Bus. L. J. (2012)

Breaking Patents32 Mich. J. Int'l L. 461 (2011)

Structure-Function Analysis for Global Pharmaceutical Linkage, 12 Minn. J. L. Science & Tech. 391 (2011) (with Ron Bouchard et al.)  

Private Ordering and Public Energy Innovation Policy, 36 Fla. St. U. L. Rev. 415 (2009) (with Leland Glenna)

Addressing the North-South Divide in Pharmaceutical Counterfeiting, 8 Wake Forest Intell. Prop. L.J. 407 (2008)

The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach, 45 Am. Bus. L.J. 283 (2008) (with Robert C. Bird)

Confronting Myths and Myopia on the Road from Doha, 42 Ga. L. Rev. 131 (2007)

Medical Product Information Incentives and the Transparency Paradox82 Ind. L.J. 623 (2007)

The Stakes Matter: Empirical Evidence of Hypothetical Bias in Case Evaluation and the Curative Power of Economic Incentives, 80 St. John's L. Rev. 1275 (2006) (with Min Ding)

Patent Fences and Constitutional Fence Posts: Property Barriers to Pharmaceutical Importation, 15 Fordham Intell. Prop., Media & Ent. L.J. 623 (2005)

Oasis or Mirage? Efficient Breach as a Relief to the Burden of Contractual Recapture of Patent and Copyright Limitations, 17 Harv. J.L. & Tech. 135 (2003)

Treating the Legal Side Effects of Cipro: A Reevaluation of Compensation Rules for Government Takings of Patent Rights, 40 Am. Bus. L.J. 125 (2002)